Abstract | BACKGROUND: METHODS: We studied 44 patients with IDC who had been treated with the therapy. LVRR was defined as LV end-diastolic dimension ≤ 55 mm and fractional shortening ≥ 25% at the last echocardiogram. RESULTS: During a mean follow-up period of 4.7 ± 3.3 years, LVRR occurred in 34% (15/44) of the patients. We divided the patients into 2 groups: (1) patients with LVRR (n = 15); (2) patients without LVRR (n = 29). The presence of atrial fibrillation was 40% in patients with LVRR and 14% in those without (p = 0.067). Initial LV end-diastolic dimension was significantly smaller (62 ± 6 vs. 67 ± 6 mm, p = 0.033) in patients with LVRR than in those without. Initial LV end-diastolic dimension of 63.5 mm was an optimal cutoff value for predicting LVRR (sensitivity: 67%, specificity: 59%, area under the curve: 0.70, p = 0.030). When patients were further allocated according to initial LV end-diastolic dimension ≤ 63.5 mm with atrial fibrillation, the combined parameter was a significant predictor of LVRR by univariate logistic regression analysis (odds ratio, 5.78, p = 0.030) (sensitivity: 33%, specificity: 97%, p = 0.013). CONCLUSIONS: Combined information on LV end-diastolic dimension and heart rhythm at diagnosis is useful in predicting future LVRR in patients with IDC.
|
Authors | Yoshihisa Matsumura, Eri Hoshikawa-Nagai, Toru Kubo, Naohito Yamasaki, Hiroaki Kitaoka, Jun Takata, Yoshinori Doi, Tetsuro Sugiura |
Journal | Cardiovascular ultrasound
(Cardiovasc Ultrasound)
Vol. 13
Pg. 14
(Mar 25 2015)
ISSN: 1476-7120 [Electronic] England |
PMID | 25880063
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
|
Topics |
- Angiotensin Receptor Antagonists
(therapeutic use)
- Angiotensin-Converting Enzyme Inhibitors
(therapeutic use)
- Cardiomyopathy, Dilated
(diagnostic imaging, drug therapy, physiopathology)
- Echocardiography
(methods)
- Female
- Humans
- Male
- Middle Aged
- Prognosis
- Recovery of Function
(drug effects, physiology)
- Reproducibility of Results
- Retrospective Studies
- Sensitivity and Specificity
- Treatment Outcome
- Ventricular Remodeling
(drug effects, physiology)
|